Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Pinto

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Indian Journal of Pathology & Microbiology|October 1, 1991
Tinea capitis due to Trichophyton schoenleiniiM P Verenkar, M J Pinto, S J Rodrigues, et al.
Cell and Tissue Banking|March 24, 2019
Quality assessment on the long-term cryopreservation and nucleic acids extraction processes implemented in the andalusian public biobankJ Ortega-Pinazo, T Díaz, B Martínez, et al.
Acta Paediatrica Belgica|April 1, 1980
Chronic B and non-B hepatitis in childhood: review of 25 casesJ P Buts, M P Van Craynest, M J Pinto, et al.
Journal of Immunological Methods|September 30, 2009
Neutralizing antibodies against IFN beta in patients with multiple sclerosis: a comparative study of two cytopathic effect tests (CPE) for their detectionB Oliver, T Orpez, C Mayorga, et al.
Neuropharmacology|July 26, 2016
Recombinant soluble IFN receptor (sIFNAR2) exhibits intrinsic therapeutic efficacy in a murine model of Multiple SclerosisM Suardíaz, D Clemente, C Marin-Bañasco, et al.
Journal of Neuroimmunology|November 26, 2010
Gene expression in IFNß signalling pathway differs between monocytes, CD4 and CD8 T cells from MS patientsB Oliver-Martos, T Órpez, M J Pinto-Medel, et al.
Arquivos Brasileiros De Cardiologia|February 1, 1985
[Verapamil in the hypertensive crisis]M Chamma Neto, M J Pinto, R I Rojas, et al.
British Journal of Pharmacology|November 25, 2016
Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosisC Marin-Bañasco, K Benabdellah, C Melero-Jerez, et al.
Molecular Biology Reports|October 9, 2023
Comparing RNA extraction methods to face the variations in RNA quality using two human biological matricesJ Ortega-Pinazo, M J Pacheco-Rodríguez, P J Serrano-Castro, et al.
Genes and Immunity|May 29, 2010
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosisA Alcina, K Vandenbroeck, D Otaegui, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Indian Journal of Pathology & Microbiology|October 1, 1991
Tinea capitis due to Trichophyton schoenleiniiM P Verenkar, M J Pinto, S J Rodrigues, et al.
Cell and Tissue Banking|March 24, 2019
Quality assessment on the long-term cryopreservation and nucleic acids extraction processes implemented in the andalusian public biobankJ Ortega-Pinazo, T Díaz, B Martínez, et al.
Acta Paediatrica Belgica|April 1, 1980
Chronic B and non-B hepatitis in childhood: review of 25 casesJ P Buts, M P Van Craynest, M J Pinto, et al.
Journal of Immunological Methods|September 30, 2009
Neutralizing antibodies against IFN beta in patients with multiple sclerosis: a comparative study of two cytopathic effect tests (CPE) for their detectionB Oliver, T Orpez, C Mayorga, et al.
Neuropharmacology|July 26, 2016
Recombinant soluble IFN receptor (sIFNAR2) exhibits intrinsic therapeutic efficacy in a murine model of Multiple SclerosisM Suardíaz, D Clemente, C Marin-Bañasco, et al.
Journal of Neuroimmunology|November 26, 2010
Gene expression in IFNß signalling pathway differs between monocytes, CD4 and CD8 T cells from MS patientsB Oliver-Martos, T Órpez, M J Pinto-Medel, et al.
Arquivos Brasileiros De Cardiologia|February 1, 1985
[Verapamil in the hypertensive crisis]M Chamma Neto, M J Pinto, R I Rojas, et al.
British Journal of Pharmacology|November 25, 2016
Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosisC Marin-Bañasco, K Benabdellah, C Melero-Jerez, et al.
Molecular Biology Reports|October 9, 2023
Comparing RNA extraction methods to face the variations in RNA quality using two human biological matricesJ Ortega-Pinazo, M J Pacheco-Rodríguez, P J Serrano-Castro, et al.
Genes and Immunity|May 29, 2010
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosisA Alcina, K Vandenbroeck, D Otaegui, et al.
Pageof 2